-
1
-
-
84865504141
-
Sterile inflammation in the liver
-
doi: 10.1053/j.gastro.2012.09.008
-
Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology (2012) 143:1158-72. doi: 10.1053/j.gastro.2012.09.008.
-
(2012)
Gastroenterology
, vol.143
, pp. 1158-1172
-
-
Kubes, P.1
Mehal, W.Z.2
-
2
-
-
79957920754
-
Inflammatory links between obesity and metabolic disease
-
doi:10.1172/JCI57132
-
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 121:2111-7. doi:10.1172/JCI57132.
-
(2011)
J Clin Invest
, vol.121
, pp. 2111-2117
-
-
Lumeng, C.N.1
Saltiel, A.R.2
-
3
-
-
47149105036
-
Toll-like receptors and adaptor molecules in liver disease: update
-
doi:10.1002/hep.22306
-
Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology (2008) 48:322-35. doi:10.1002/hep.22306.
-
(2008)
Hepatology
, vol.48
, pp. 322-335
-
-
Seki, E.1
Brenner, D.A.2
-
4
-
-
61849170035
-
TLRs and innate immunity
-
doi:10.1182/blood-2008-07-019307
-
Beutler BA. TLRs and innate immunity. Blood (2009) 113:1399-407. doi:10.1182/blood-2008-07-019307.
-
(2009)
Blood
, vol.113
, pp. 1399-1407
-
-
Beutler, B.A.1
-
5
-
-
35748950109
-
Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease
-
doi:10.1111/j.1600-065X.2007.00577.x
-
Beutler B. Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease. Immunol Rev (2007) 220:113-28. doi:10.1111/j.1600-065X.2007.00577.x.
-
(2007)
Immunol Rev
, vol.220
, pp. 113-128
-
-
Beutler, B.1
-
6
-
-
33845951211
-
DAMPs, PAMPs and alarmins: all we need to know about danger
-
doi:10.1189/jlb.0306164
-
Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2007) 81:1-5. doi:10.1189/jlb.0306164.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 1-5
-
-
Bianchi, M.E.1
-
7
-
-
35748945719
-
The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity
-
doi:10.1111/j.1600-065X.2007.00579.x
-
Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev (2007) 220:60-81. doi:10.1111/j.1600-065X.2007.00579.x.
-
(2007)
Immunol Rev
, vol.220
, pp. 60-81
-
-
Lotze, M.T.1
Zeh, H.J.2
Rubartelli, A.3
Sparvero, L.J.4
Amoscato, A.A.5
Washburn, N.R.6
-
8
-
-
0030669392
-
A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
-
doi:10.1074/jbc.272.47.29911
-
Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem (1997) 272:29911-8. doi:10.1074/jbc.272.47.29911.
-
(1997)
J Biol Chem
, vol.272
, pp. 29911-29918
-
-
Paz, K.1
Hemi, R.2
LeRoith, D.3
Karasik, A.4
Elhanany, E.5
Kanety, H.6
-
9
-
-
33646014467
-
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
-
doi:10.1111/j.1478-3231.2005.01191.x
-
Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K, et al. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int (2006) 26:39-45. doi:10.1111/j.1478-3231.2005.01191.x.
-
(2006)
Liver Int
, vol.26
, pp. 39-45
-
-
Abiru, S.1
Migita, K.2
Maeda, Y.3
Daikoku, M.4
Ito, M.5
Ohata, K.6
-
10
-
-
34250632770
-
Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease
-
doi:10.1309/6VJ4DWGYDU0XYJ8Q
-
Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol (2007) 127:954-60. doi:10.1309/6VJ4DWGYDU0XYJ8Q.
-
(2007)
Am J Clin Pathol
, vol.127
, pp. 954-960
-
-
Manco, M.1
Marcellini, M.2
Giannone, G.3
Nobili, V.4
-
11
-
-
33646161443
-
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
-
doi:10.1016/j.jhep.2006.02.011
-
Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol (2006) 44:1167-74. doi:10.1016/j.jhep.2006.02.011.
-
(2006)
J Hepatol
, vol.44
, pp. 1167-1174
-
-
Haukeland, J.W.1
Damås, J.K.2
Konopski, Z.3
Løberg, E.M.4
Haaland, T.5
Goverud, I.6
-
12
-
-
78649498271
-
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity
-
doi:10.1016/j.cmet.2010.11.011
-
Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab (2010) 12:593-605. doi:10.1016/j.cmet.2010.11.011.
-
(2010)
Cell Metab
, vol.12
, pp. 593-605
-
-
Stienstra, R.1
Joosten, L.A.2
Koenen, T.3
van Tits, B.4
van Diepen, J.A.5
van den Berg, S.A.6
-
13
-
-
79751512463
-
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
-
doi:10.1038/nm.2279
-
Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med (2011) 17:179-88. doi:10.1038/nm.2279.
-
(2011)
Nat Med
, vol.17
, pp. 179-188
-
-
Vandanmagsar, B.1
Youm, Y.H.2
Ravussin, A.3
Galgani, J.E.4
Stadler, K.5
Mynatt, R.L.6
-
14
-
-
56749164791
-
Nutrient sensing and inflammation in metabolic diseases
-
doi:10.1038/nri2449
-
Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 8:923-34. doi:10.1038/nri2449.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 923-934
-
-
Hotamisligil, G.S.1
Erbay, E.2
-
15
-
-
77952565420
-
The role of cytokines in non-alcoholic fatty liver disease
-
doi:10.1159/000282083
-
Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis (2010) 28:179-85. doi:10.1159/000282083.
-
(2010)
Dig Dis
, vol.28
, pp. 179-185
-
-
Tilg, H.1
-
17
-
-
0035053878
-
The lymphoid liver: considerations on pathways to autoimmune injury
-
doi:10.1053/gast.2001.22441
-
Kita H, Mackay IR, Van De Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology (2001) 120:1485-501. doi:10.1053/gast.2001.22441.
-
(2001)
Gastroenterology
, vol.120
, pp. 1485-1501
-
-
Kita, H.1
Mackay, I.R.2
Van De Water, J.3
Gershwin, M.E.4
-
18
-
-
71149092271
-
Immune-mediated liver injury
-
doi:10.1016/j.jhep.2009.10.016
-
Lohse AW, Weiler-Normann C, Tiegs G. Immune-mediated liver injury. J Hepatol (2010) 52:136-44. doi:10.1016/j.jhep.2009.10.016.
-
(2010)
J Hepatol
, vol.52
, pp. 136-144
-
-
Lohse, A.W.1
Weiler-Normann, C.2
Tiegs, G.3
-
19
-
-
75149196666
-
Immune tolerance: what is unique about the liver
-
doi:10.1016/j.jaut.2009.08.008
-
Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun (2010) 34:1-6. doi:10.1016/j.jaut.2009.08.008.
-
(2010)
J Autoimmun
, vol.34
, pp. 1-6
-
-
Tiegs, G.1
Lohse, A.W.2
-
20
-
-
80052468996
-
Mechanisms balancing tolerance and immunity in the liver
-
doi:10.1159/000329801
-
Bottcher JP, Knolle PA, Stabenow D. Mechanisms balancing tolerance and immunity in the liver. Dig Dis (2011) 29:384-90. doi:10.1159/000329801.
-
(2011)
Dig Dis
, vol.29
, pp. 384-390
-
-
Bottcher, J.P.1
Knolle, P.A.2
Stabenow, D.3
-
21
-
-
84858754943
-
Immune functioning in non lymphoid organs: the liver
-
doi:10.1177/0192623311428475
-
Parker GA, Picut CA. Immune functioning in non lymphoid organs: the liver. Toxicol Pathol (2012) 40:237-47. doi:10.1177/0192623311428475.
-
(2012)
Toxicol Pathol
, vol.40
, pp. 237-247
-
-
Parker, G.A.1
Picut, C.A.2
-
22
-
-
67650750880
-
The liver as a lymphoid organ
-
doi:10.1146/annurev.immunol.021908.132629
-
Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol (2009) 27:147-63. doi:10.1146/annurev.immunol.021908.132629.
-
(2009)
Annu Rev Immunol
, vol.27
, pp. 147-163
-
-
Crispe, I.N.1
-
23
-
-
77954961993
-
Toll-like receptor 4 and hepatic fibrogenesis
-
doi:10.1055/s-0030-1255353
-
Pradere JP, Troeger JS, Dapito DH, Mencin AA, Schwabe RF. Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis (2010) 30:232-44. doi:10.1055/s-0030-1255353.
-
(2010)
Semin Liver Dis
, vol.30
, pp. 232-244
-
-
Pradere, J.P.1
Troeger, J.S.2
Dapito, D.H.3
Mencin, A.A.4
Schwabe, R.F.5
-
24
-
-
84875466830
-
IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells
-
doi:10.4049/jimmunol.1203218
-
Tang XZ, Jo J, Tan AT, Sandalova E, Chia A, Tan KC, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol (2013) 190:3142-52. doi:10.4049/jimmunol.1203218.
-
(2013)
J Immunol
, vol.190
, pp. 3142-3152
-
-
Tang, X.Z.1
Jo, J.2
Tan, A.T.3
Sandalova, E.4
Chia, A.5
Tan, K.C.6
-
25
-
-
84866410095
-
Regulatory T cells in autoimmune hepatitis
-
doi:10.1016/j.jhep.2012.05.022
-
Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Regulatory T cells in autoimmune hepatitis. J Hepatol (2012) 57:932-3. doi:10.1016/j.jhep.2012.05.022.
-
(2012)
J Hepatol
, vol.57
, pp. 932-933
-
-
Longhi, M.S.1
Ma, Y.2
Mieli-Vergani, G.3
Vergani, D.4
-
26
-
-
77951620158
-
Dynamic imaging of host-pathogen interactions in vivo
-
doi:10.1038/nri2746
-
Coombes JL, Robey EA. Dynamic imaging of host-pathogen interactions in vivo. Nat Rev Immunol (2010) 10:353-64. doi:10.1038/nri2746.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 353-364
-
-
Coombes, J.L.1
Robey, E.A.2
-
27
-
-
78751576088
-
Liver antigen-presenting cells
-
doi:10.1016/j.jhep.2010.10.005
-
Crispe IN. Liver antigen-presenting cells. J Hepatol (2011) 54:357-65. doi:10.1016/j.jhep.2010.10.005.
-
(2011)
J Hepatol
, vol.54
, pp. 357-365
-
-
Crispe, I.N.1
-
28
-
-
77958557979
-
Antigen-presenting cell function in the tolerogenic liver environment
-
doi:10.1038/nri2858
-
Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol (2010) 10:753-66. doi:10.1038/nri2858.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 753-766
-
-
Thomson, A.W.1
Knolle, P.A.2
-
29
-
-
84881552070
-
Apotopes and innate immune system: novel players in the primary biliary cirrhosis scenario
-
doi:10.1016/j.dld.2013.01.005
-
Lleo A, Invernizzi P. Apotopes and innate immune system: novel players in the primary biliary cirrhosis scenario. Dig Liver Dis (2013) 45:630-6. doi:10.1016/j.dld.2013.01.005.
-
(2013)
Dig Liver Dis
, vol.45
, pp. 630-636
-
-
Lleo, A.1
Invernizzi, P.2
-
30
-
-
0020379865
-
Relation between localization and function of rat liver Kupffer cells
-
Sleyster EC, Knook DL. Relation between localization and function of rat liver Kupffer cells. Lab Invest (1982) 47:484-90.
-
(1982)
Lab Invest
, vol.47
, pp. 484-490
-
-
Sleyster, E.C.1
Knook, D.L.2
-
31
-
-
84859508307
-
A lineage of myeloid cells independent of Myb and hematopoietic stem cells
-
doi:10.1126/science.1219179
-
Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 336:86-90. doi:10.1126/science.1219179.
-
(2012)
Science
, vol.336
, pp. 86-90
-
-
Schulz, C.1
Gomez Perdiguero, E.2
Chorro, L.3
Szabo-Rogers, H.4
Cagnard, N.5
Kierdorf, K.6
-
32
-
-
0027949024
-
Cell biology of liver endothelial and Kupffer cells
-
doi:10.1136/gut.35.11.1509
-
Smedsrod B, De Bleser PJ, Braet F, Lovisetti P, Vanderkerken K, Wisse E, et al. Cell biology of liver endothelial and Kupffer cells. Gut (1994) 35:1509-16. doi:10.1136/gut.35.11.1509.
-
(1994)
Gut
, vol.35
, pp. 1509-1516
-
-
Smedsrod, B.1
De Bleser, P.J.2
Braet, F.3
Lovisetti, P.4
Vanderkerken, K.5
Wisse, E.6
-
33
-
-
33750999322
-
Role of Kupffer cells in host defense and liver disease
-
doi:10.1111/j.1478-3231.2006.01342.x
-
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int (2006) 26:1175-86. doi:10.1111/j.1478-3231.2006.01342.x.
-
(2006)
Liver Int
, vol.26
, pp. 1175-1186
-
-
Bilzer, M.1
Roggel, F.2
Gerbes, A.L.3
-
34
-
-
0028130057
-
Fc receptors: rubor redux
-
doi:10.1016/0092-8674(94)90521-5
-
Ravetch JV. Fc receptors: rubor redux. Cell (1994) 78:553-60. doi:10.1016/0092-8674(94)90521-5.
-
(1994)
Cell
, vol.78
, pp. 553-560
-
-
Ravetch, J.V.1
-
35
-
-
1942424773
-
Differentiation and function of Kupffer cells
-
doi:10.1007/s00795-003-0228-x
-
Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc (2004) 37:16-28. doi:10.1007/s00795-003-0228-x.
-
(2004)
Med Electron Microsc
, vol.37
, pp. 16-28
-
-
Naito, M.1
Hasegawa, G.2
Ebe, Y.3
Yamamoto, T.4
-
36
-
-
0036074141
-
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
-
doi:10.1152/ajpgi.00550.2001
-
Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol (2002) 283:G256-65. doi:10.1152/ajpgi.00550.2001.
-
(2002)
Am J Physiol Gastrointest Liver Physiol
, vol.283
-
-
Su, G.L.1
-
37
-
-
0036785630
-
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice
-
Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 169:3863-8.
-
(2002)
J Immunol
, vol.169
, pp. 3863-3868
-
-
Seki, E.1
Tsutsui, H.2
Tsuji, N.M.3
Hayashi, N.4
Adachi, K.5
Nakano, H.6
-
38
-
-
0028917669
-
Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge
-
doi:10.1016/0168-8278(95)80433-1
-
Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol (1995) 22:226-9. doi:10.1016/0168-8278(95)80433-1.
-
(1995)
J Hepatol
, vol.22
, pp. 226-229
-
-
Knolle, P.1
Schlaak, J.2
Uhrig, A.3
Kempf, P.4
Meyer Zum Buschenfelde, K.H.5
Gerken, G.6
-
39
-
-
0035865249
-
Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β
-
Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol (2001) 166:2651-7.
-
(2001)
J Immunol
, vol.166
, pp. 2651-2657
-
-
Seki, E.1
Tsutsui, H.2
Nakano, H.3
Tsuji, N.4
Hoshino, K.5
Adachi, O.6
-
40
-
-
0033179531
-
Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo
-
Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol (1999) 163:1537-44.
-
(1999)
J Immunol
, vol.163
, pp. 1537-1544
-
-
Kopydlowski, K.M.1
Salkowski, C.A.2
Cody, M.J.3
van Rooijen, N.4
Major, J.5
Hamilton, T.A.6
-
41
-
-
0034083632
-
Pathophysiological roles of interleukin-18 in inflammatory liver diseases
-
doi:10.1034/j.1600-0528.2002.017418.x
-
Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev (2000) 174:192-209. doi:10.1034/j.1600-0528.2002.017418.x.
-
(2000)
Immunol Rev
, vol.174
, pp. 192-209
-
-
Tsutsui, H.1
Matsui, K.2
Okamura, H.3
Nakanishi, K.4
-
42
-
-
84857883847
-
Macrophage plasticity and polarization: in vivo veritas
-
doi:10.1172/JCI59643
-
Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122:787-95. doi:10.1172/JCI59643.
-
(2012)
J Clin Invest
, vol.122
, pp. 787-795
-
-
Sica, A.1
Mantovani, A.2
-
43
-
-
84859464555
-
Orchestration of metabolism by macrophages
-
doi:10.1016/j.cmet.2011.11.013
-
Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab (2012) 15:432-7. doi:10.1016/j.cmet.2011.11.013.
-
(2012)
Cell Metab
, vol.15
, pp. 432-437
-
-
Biswas, S.K.1
Mantovani, A.2
-
44
-
-
2342464085
-
The two NF-kappaB activation pathways and their role in innate and adaptive immunity
-
doi:10.1016/j.it.2004.03.008
-
Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol (2004) 25:280-8. doi:10.1016/j.it.2004.03.008.
-
(2004)
Trends Immunol
, vol.25
, pp. 280-288
-
-
Bonizzi, G.1
Karin, M.2
-
45
-
-
34147190086
-
Chronic inflammation: a failure of resolution?
-
doi:10.1111/j.1365-2613.2006.00507.x
-
Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution? Int J Exp Pathol (2007) 88:85-94. doi:10.1111/j.1365-2613.2006.00507.x.
-
(2007)
Int J Exp Pathol
, vol.88
, pp. 85-94
-
-
Lawrence, T.1
Gilroy, D.W.2
-
46
-
-
45149134605
-
"Re-educating" tumor-associated macrophages by targeting NF-kappaB
-
doi:10.1084/jem.20080108
-
Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 205:1261-8. doi:10.1084/jem.20080108.
-
(2008)
J Exp Med
, vol.205
, pp. 1261-1268
-
-
Hagemann, T.1
Lawrence, T.2
McNeish, I.3
Charles, K.A.4
Kulbe, H.5
Thompson, R.G.6
-
47
-
-
84905215762
-
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease
-
doi:10.1007/s10238-012-0227-0.
-
Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med (2013). doi:10.1007/s10238-012-0227-0.
-
(2013)
Clin Exp Med
-
-
Gatselis, N.K.1
Ntaios, G.2
Makaritsis, K.3
Dalekos, G.N.4
-
48
-
-
77649177217
-
Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis
-
doi:10.1101/gad.1881410
-
Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, et al. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev (2010) 24:491-501. doi:10.1101/gad.1881410.
-
(2010)
Genes Dev
, vol.24
, pp. 491-501
-
-
Takeda, N.1
O'Dea, E.L.2
Doedens, A.3
Kim, J.W.4
Weidemann, A.5
Stockmann, C.6
-
49
-
-
84872142459
-
JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation
-
doi:10.1126/science.1227568
-
Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science (2013) 339:218-22. doi:10.1126/science.1227568.
-
(2013)
Science
, vol.339
, pp. 218-222
-
-
Han, M.S.1
Jung, D.Y.2
Morel, C.3
Lakhani, S.A.4
Kim, J.K.5
Flavell, R.A.6
-
50
-
-
84872577084
-
Cell surface receptor FPR2 promotes antitumor host defense by limiting m2 polarization of macrophages
-
doi:10.1158/0008-5472.CAN-12-2290
-
Liu Y, Chen K, Wang C, Gong W, Yoshimura T, Liu M, et al. Cell surface receptor FPR2 promotes antitumor host defense by limiting m2 polarization of macrophages. Cancer Res (2013) 73:550-60. doi:10.1158/0008-5472.CAN-12-2290.
-
(2013)
Cancer Res
, vol.73
, pp. 550-560
-
-
Liu, Y.1
Chen, K.2
Wang, C.3
Gong, W.4
Yoshimura, T.5
Liu, M.6
-
51
-
-
0036084728
-
Role of toll-like receptors in changes in gene expression and NFkappa B activation in mouse hepatocytes stimulated with lipopolysaccharide
-
doi:10.1128/IAI.70.7.3433-3442.2002
-
Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, et al. Role of toll-like receptors in changes in gene expression and NFkappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun (2002) 70:3433-42. doi:10.1128/IAI.70.7.3433-3442.2002.
-
(2002)
Infect Immun
, vol.70
, pp. 3433-3442
-
-
Liu, S.1
Gallo, D.J.2
Green, A.M.3
Williams, D.L.4
Gong, X.5
Shapiro, R.A.6
-
52
-
-
0037954044
-
TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes
-
doi:10.1046/j.1365-2567.2003.01627.x
-
Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J, et al. TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology (2003) 109:127-36. doi:10.1046/j.1365-2567.2003.01627.x.
-
(2003)
Immunology
, vol.109
, pp. 127-136
-
-
Matsumura, T.1
Degawa, T.2
Takii, T.3
Hayashi, H.4
Okamoto, T.5
Inoue, J.6
-
53
-
-
0028804229
-
Role of hepatocytes in direct clearance of lipopolysaccharide in rats
-
doi:10.1016/0016-5085(95)90765-3
-
Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology (1995) 109:1969-76. doi:10.1016/0016-5085(95)90765-3.
-
(1995)
Gastroenterology
, vol.109
, pp. 1969-1976
-
-
Mimura, Y.1
Sakisaka, S.2
Harada, M.3
Sata, M.4
Tanikawa, K.5
-
54
-
-
57649142987
-
Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes
-
doi:10.1074/jbc.M803905200
-
Scott MJ, Billiar TR. Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem (2008) 283:29433-46. doi:10.1074/jbc.M803905200.
-
(2008)
J Biol Chem
, vol.283
, pp. 29433-29446
-
-
Scott, M.J.1
Billiar, T.R.2
-
55
-
-
35948954244
-
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
-
doi:10.1152/physrev.00013.2007
-
Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 88:125-72. doi:10.1152/physrev.00013.2007.
-
(2008)
Physiol Rev
, vol.88
, pp. 125-172
-
-
Friedman, S.L.1
-
56
-
-
67349229867
-
Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage
-
doi:10.1016/j.bbalip.2008.11.001
-
Blaner WS, O'Byrne SM, Wongsiriroj N, Kluwe J, D'Ambrosio DM, Jiang H, et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta (2009) 1791:467-73. doi:10.1016/j.bbalip.2008.11.001.
-
(2009)
Biochim Biophys Acta
, vol.1791
, pp. 467-473
-
-
Blaner, W.S.1
O'Byrne, S.M.2
Wongsiriroj, N.3
Kluwe, J.4
D'Ambrosio, D.M.5
Jiang, H.6
-
57
-
-
46049103960
-
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C
-
doi:10.1002/lt.21436
-
Carotti S, Morini S, Corradini SG, Burza MA, Molinaro A, Carpino G, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl (2008) 14:806-14. doi:10.1002/lt.21436.
-
(2008)
Liver Transpl
, vol.14
, pp. 806-814
-
-
Carotti, S.1
Morini, S.2
Corradini, S.G.3
Burza, M.A.4
Molinaro, A.5
Carpino, G.6
-
58
-
-
13144307093
-
Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study
-
Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. Ital J Anat Embryol (2004) 109:225-38.
-
(2004)
Ital J Anat Embryol
, vol.109
, pp. 225-238
-
-
Carpino, G.1
Franchitto, A.2
Morini, S.3
Corradini, S.G.4
Merli, M.5
Gaudio, E.6
-
59
-
-
24044447311
-
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation
-
doi:10.1016/j.dld.2004.11.009
-
Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis (2005) 37:349-56. doi:10.1016/j.dld.2004.11.009.
-
(2005)
Dig Liver Dis
, vol.37
, pp. 349-356
-
-
Carpino, G.1
Morini, S.2
Ginanni Corradini, S.3
Franchitto, A.4
Merli, M.5
Siciliano, M.6
-
60
-
-
84863098121
-
Inflammation and fibrogenesis in steatohepatitis
-
doi:10.1007/s00535-012-0527-x
-
Fujii H, Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol (2012) 47:215-25. doi:10.1007/s00535-012-0527-x.
-
(2012)
J Gastroenterol
, vol.47
, pp. 215-225
-
-
Fujii, H.1
Kawada, N.2
-
61
-
-
33747616182
-
Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation
-
doi:10.1111/j.1440-1746.2006.04573.x
-
Tsukamoto H, She H, Hazra S, Cheng J, Miyahara T. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol (2006) 21:S102-5. doi:10.1111/j.1440-1746.2006.04573.x.
-
(2006)
J Gastroenterol Hepatol
, vol.21
-
-
Tsukamoto, H.1
She, H.2
Hazra, S.3
Cheng, J.4
Miyahara, T.5
-
62
-
-
79959789940
-
Epigenetic cell fate regulation of hepatic stellate cells
-
doi:10.1111/j.1872-034X.2011.00804.x
-
Tsukamoto H, Zhu NL, Asahina K, Mann DA, Mann J. Epigenetic cell fate regulation of hepatic stellate cells. Hepatol Res (2011) 41:675-82. doi:10.1111/j.1872-034X.2011.00804.x.
-
(2011)
Hepatol Res
, vol.41
, pp. 675-682
-
-
Tsukamoto, H.1
Zhu, N.L.2
Asahina, K.3
Mann, D.A.4
Mann, J.5
-
63
-
-
77954234732
-
Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells
-
doi:10.1002/hep.23649
-
Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, et al. Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology (2010) 52:278-90. doi:10.1002/hep.23649.
-
(2010)
Hepatology
, vol.52
, pp. 278-290
-
-
Choi, S.S.1
Witek, R.P.2
Yang, L.3
Omenetti, A.4
Syn, W.K.5
Moylan, C.A.6
-
65
-
-
78449240951
-
Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway
-
doi:10.1074/jbc.M110.168542
-
Choi SS, Syn WK, Karaca GF, Omenetti A, Moylan CA, Witek RP, et al. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem (2010) 285:36551-60. doi:10.1074/jbc.M110.168542.
-
(2010)
J Biol Chem
, vol.285
, pp. 36551-36560
-
-
Choi, S.S.1
Syn, W.K.2
Karaca, G.F.3
Omenetti, A.4
Moylan, C.A.5
Witek, R.P.6
-
66
-
-
25844472239
-
Adipokines and liver fibrosis
-
Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F. Adipokines and liver fibrosis. Eur Rev Med Pharmacol Sci (2005) 9:279-84.
-
(2005)
Eur Rev Med Pharmacol Sci
, vol.9
, pp. 279-284
-
-
Marra, F.1
Aleffi, S.2
Bertolani, C.3
Petrai, I.4
Vizzutti, F.5
-
67
-
-
0036234147
-
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat
-
doi:10.1053/gast.2002.32995
-
Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology (2002) 122:1399-410. doi:10.1053/gast.2002.32995.
-
(2002)
Gastroenterology
, vol.122
, pp. 1399-1410
-
-
Ikejima, K.1
Takei, Y.2
Honda, H.3
Hirose, M.4
Yoshikawa, M.5
Zhang, Y.J.6
-
68
-
-
0037772442
-
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II
-
doi:10.1016/S0016-5085(03)00695-4
-
Bataller R, Sancho-Bru P, Ginés P, Lora JM, Al-Garawi A, Solè M, et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology (2003) 125:117-25. doi:10.1016/S0016-5085(03)00695-4.
-
(2003)
Gastroenterology
, vol.125
, pp. 117-125
-
-
Bataller, R.1
Sancho-Bru, P.2
Ginés, P.3
Lora, J.M.4
Al-Garawi, A.5
Solè, M.6
-
69
-
-
0034120267
-
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
-
doi:10.1016/S0016-5085(00)70368-4
-
Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology (2000) 118:1149-56. doi:10.1016/S0016-5085(00)70368-4.
-
(2000)
Gastroenterology
, vol.118
, pp. 1149-1156
-
-
Bataller, R.1
Ginès, P.2
Nicolás, J.M.3
Görbig, M.N.4
Garcia-Ramallo, E.5
Gasull, X.6
-
70
-
-
0347986777
-
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
-
doi:10.1172/JCI18212
-
Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest (2003) 112:1383-94. doi:10.1172/JCI18212.
-
(2003)
J Clin Invest
, vol.112
, pp. 1383-1394
-
-
Bataller, R.1
Schwabe, R.F.2
Choi, Y.H.3
Yang, L.4
Paik, Y.H.5
Lindquist, J.6
-
71
-
-
35948958955
-
TLR4 enhances TGF-beta signaling and hepatic fibrosis
-
doi:10.1038/nm1663
-
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med (2007) 13:1324-32. doi:10.1038/nm1663.
-
(2007)
Nat Med
, vol.13
, pp. 1324-1332
-
-
Seki, E.1
De Minicis, S.2
Osterreicher, C.H.3
Kluwe, J.4
Osawa, Y.5
Brenner, D.A.6
-
72
-
-
79957930356
-
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats
-
doi:10.1152/ajpgi.00365.2010
-
Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, et al. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. Am J Physiol Gastrointest Liver Physiol (2011) 300:G1094-104. doi:10.1152/ajpgi.00365.2010.
-
(2011)
Am J Physiol Gastrointest Liver Physiol
, vol.300
-
-
Kaji, K.1
Yoshiji, H.2
Kitade, M.3
Ikenaka, Y.4
Noguchi, R.5
Shirai, Y.6
-
73
-
-
79959330628
-
Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease
-
doi:10.1136/jcp.2011.090175
-
Chiba M, Sasaki M, Kitamura S, Ikeda H, Sato Y, Nakanuma Y. Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. J Clin Pathol (2011) 64:564-70. doi:10.1136/jcp.2011.090175.
-
(2011)
J Clin Pathol
, vol.64
, pp. 564-570
-
-
Chiba, M.1
Sasaki, M.2
Kitamura, S.3
Ikeda, H.4
Sato, Y.5
Nakanuma, Y.6
-
74
-
-
0242413703
-
Lipopolysaccharide activates nuclear factor-kB through toll-like receptors and related molecules in cultured biliary epithelial cells
-
doi:10.1097/01.LAB.0000097190.56734.FE
-
Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, et al. Lipopolysaccharide activates nuclear factor-kB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest (2003) 83:1657-67. doi:10.1097/01.LAB.0000097190.56734.FE.
-
(2003)
Lab Invest
, vol.83
, pp. 1657-1667
-
-
Harada, K.1
Ohira, S.2
Isse, K.3
Ozaki, S.4
Zen, Y.5
Sato, Y.6
-
75
-
-
34249045984
-
Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture
-
doi:10.1038/labinvest.3700556
-
Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Zen Y, et al. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest (2007) 87:559-71. doi:10.1038/labinvest.3700556.
-
(2007)
Lab Invest
, vol.87
, pp. 559-571
-
-
Ikeda, H.1
Sasaki, M.2
Ishikawa, A.3
Sato, Y.4
Harada, K.5
Zen, Y.6
-
76
-
-
28244478101
-
Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB
-
Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol (2005) 175:7447-56.
-
(2005)
J Immunol
, vol.175
, pp. 7447-7456
-
-
Chen, X.M.1
O'Hara, S.P.2
Nelson, J.B.3
Splinter, P.L.4
Small, A.J.5
Tietz, P.S.6
-
77
-
-
32544446183
-
Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction
-
doi:10.1136/jcp.2004.023507
-
Harada K, Isse K, Nakanuma Y. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol (2006) 59:184-90. doi:10.1136/jcp.2004.023507.
-
(2006)
J Clin Pathol
, vol.59
, pp. 184-190
-
-
Harada, K.1
Isse, K.2
Nakanuma, Y.3
-
78
-
-
13544263583
-
Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin
-
De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol (2005) 174:2037-45.
-
(2005)
J Immunol
, vol.174
, pp. 2037-2045
-
-
De Creus, A.1
Abe, M.2
Lau, A.H.3
Hackstein, H.4
Raimondi, G.5
Thomson, A.W.6
-
79
-
-
34447338577
-
The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses
-
doi:10.1111/j.1365-2249.2007.03419.x
-
Shu SA, Lian ZX, Chuang YH, Yang GX, Moritoki Y, Comstock SS, et al. The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses. Clin Exp Immunol (2007) 149:335-43. doi:10.1111/j.1365-2249.2007.03419.x.
-
(2007)
Clin Exp Immunol
, vol.149
, pp. 335-343
-
-
Shu, S.A.1
Lian, Z.X.2
Chuang, Y.H.3
Yang, G.X.4
Moritoki, Y.5
Comstock, S.S.6
-
80
-
-
18244364834
-
Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver
-
doi:10.1189/jlb.0604332
-
Uhrig A, Banafsche R, Kremer M, Hegenbarth S, Hamann A, Neurath M, et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol (2005) 77:626-33. doi:10.1189/jlb.0604332.
-
(2005)
J Leukoc Biol
, vol.77
, pp. 626-633
-
-
Uhrig, A.1
Banafsche, R.2
Kremer, M.3
Hegenbarth, S.4
Hamann, A.5
Neurath, M.6
-
81
-
-
37749050365
-
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
-
doi:10.1002/hep.21897
-
Wu J, Lu M, Meng Z, Jiang M, Pei R, Trippler M, et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology (2007) 46:1769-78. doi:10.1002/hep.21897.
-
(2007)
Hepatology
, vol.46
, pp. 1769-1778
-
-
Wu, J.1
Lu, M.2
Meng, Z.3
Jiang, M.4
Pei, R.5
Trippler, M.6
-
82
-
-
0024207738
-
Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts
-
doi:10.1016/S0168-8278(88)80005-9
-
Van Bossuyt H, De Zanger RB, Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol (1988) 7:325-37. doi:10.1016/S0168-8278(88)80005-9.
-
(1988)
J Hepatol
, vol.7
, pp. 325-337
-
-
Van Bossuyt, H.1
De Zanger, R.B.2
Wisse, E.3
-
83
-
-
77950343791
-
Pattern recognition receptors and inflammation
-
doi:10.1016/j.cell.2010.01.022
-
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell (2010) 140:805-20. doi:10.1016/j.cell.2010.01.022.
-
(2010)
Cell
, vol.140
, pp. 805-820
-
-
Takeuchi, O.1
Akira, S.2
-
84
-
-
79251563125
-
Current views of toll-like receptor signaling pathways
-
doi:10.1155/2010/240365
-
Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract (2010) 2010:240365. doi:10.1155/2010/240365.
-
(2010)
Gastroenterol Res Pract
, vol.2010
, pp. 240365
-
-
Yamamoto, M.1
Takeda, K.2
-
85
-
-
78751560494
-
Pathogen recognition by the innate immune system
-
doi:10.3109/08830185.2010.529976
-
Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 30:1-34. doi:10.3109/08830185.2010.529976.
-
(2011)
Int Rev Immunol
, vol.30
, pp. 1-34
-
-
Kumar, H.1
Kawai, T.2
Akira, S.3
-
86
-
-
79953061608
-
Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological and clinical genetics
-
doi:10.1146/annurev-immunol-030409-101335
-
Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological and clinical genetics. Annu Rev Immunol (2011) 29:447-91. doi:10.1146/annurev-immunol-030409-101335.
-
(2011)
Annu Rev Immunol
, vol.29
, pp. 447-491
-
-
Casanova, J.L.1
Abel, L.2
Quintana-Murci, L.3
-
87
-
-
78651496241
-
Toll-like receptors as interferon-regulated genes and their role in disease
-
doi:10.1089/jir.2010.0095
-
Khoo JJ, Forster S, Mansell A. Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res (2011) 31:13-25. doi:10.1089/jir.2010.0095.
-
(2011)
J Interferon Cytokine Res
, vol.31
, pp. 13-25
-
-
Khoo, J.J.1
Forster, S.2
Mansell, A.3
-
88
-
-
47149105036
-
Toll-like receptors and adaptor molecules in liver disease: updates
-
doi:10.1002/hep.22306
-
Ekihiro S, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: updates. Hepatology (2008) 48:322-35. doi:10.1002/hep.22306.
-
(2008)
Hepatology
, vol.48
, pp. 322-335
-
-
Ekihiro, S.1
Brenner, D.A.2
-
89
-
-
77956810224
-
Toll-like receptor signalling and liver fibrosis
-
doi:10.1155/2010/192543
-
Aoyama T, Paik YH, Seki E. Toll-like receptor signalling and liver fibrosis. Gastroenterol Res Pract (2010) 2010:192543. doi:10.1155/2010/192543.
-
(2010)
Gastroenterol Res Pract
, vol.2010
, pp. 192543
-
-
Aoyama, T.1
Paik, Y.H.2
Seki, E.3
-
90
-
-
78349238211
-
TLRs, NF-kB, JNK, and liver regeneration
-
doi:10.1155/2010/598109
-
Iimuro Y, Fujimoto J. TLRs, NF-kB, JNK, and liver regeneration. Gastroenterol Res Pract (2010) 2010:598109. doi:10.1155/2010/598109.
-
(2010)
Gastroenterol Res Pract
, vol.2010
, pp. 598109
-
-
Iimuro, Y.1
Fujimoto, J.2
-
91
-
-
77249160271
-
Localisation and trafficking of Toll-like receptors: an important mode of regulation
-
doi:10.1016/j.coi.2009.12.002
-
McGettrick AF, O'Neill LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol (2010) 22:20-7. doi:10.1016/j.coi.2009.12.002.
-
(2010)
Curr Opin Immunol
, vol.22
, pp. 20-27
-
-
McGettrick, A.F.1
O'Neill, L.A.2
-
92
-
-
80052365243
-
Role of Toll-like receptors in liver health and disease
-
doi:10.1042/CS20110065
-
Broering R, Lu M, Schlaak JF. Role of Toll-like receptors in liver health and disease. Clin Sci (Lond) (2011) 121:415-26. doi:10.1042/CS20110065.
-
(2011)
Clin Sci (Lond)
, vol.121
, pp. 415-426
-
-
Broering, R.1
Lu, M.2
Schlaak, J.F.3
-
93
-
-
77953891627
-
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice
-
doi:10.1053/j.gastro.2010.03.052
-
Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology (2010) 139:323-34. doi:10.1053/j.gastro.2010.03.052.
-
(2010)
Gastroenterology
, vol.139
, pp. 323-334
-
-
Miura, K.1
Kodama, Y.2
Inokuchi, S.3
Schnabl, B.4
Aoyama, T.5
Ohnishi, H.6
-
94
-
-
77952688386
-
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
-
doi:10.1186/1471-230X-10-52
-
Rivera CA, Gaskin L, Allman M, Pang J, Brady K, Adegboyega P, et al. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis. BMC Gastroenterol (2010) 10:52. doi:10.1186/1471-230X-10-52.
-
(2010)
BMC Gastroenterol
, vol.10
, pp. 52
-
-
Rivera, C.A.1
Gaskin, L.2
Allman, M.3
Pang, J.4
Brady, K.5
Adegboyega, P.6
-
95
-
-
79954523464
-
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice
-
doi:10.1152/ajpgi.00163.2009
-
Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol (2011) 300:433-41. doi:10.1152/ajpgi.00163.2009.
-
(2011)
Am J Physiol Gastrointest Liver Physiol
, vol.300
, pp. 433-441
-
-
Csak, T.1
Velayudham, A.2
Hritz, I.3
Petrasek, J.4
Levin, I.5
Lippai, D.6
-
96
-
-
70350075402
-
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
-
doi:10.1002/hep.23122
-
Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology (2009) 50:1094-104. doi:10.1002/hep.23122.
-
(2009)
Hepatology
, vol.50
, pp. 1094-1104
-
-
Spruss, A.1
Kanuri, G.2
Wagnerberger, S.3
Haub, S.4
Bischoff, S.C.5
Bergheim, I.6
-
97
-
-
75449096565
-
Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury
-
doi:10.1002/hep.23365
-
Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology (2010) 51:621-32. doi:10.1002/hep.23365.
-
(2010)
Hepatology
, vol.51
, pp. 621-632
-
-
Bamboat, Z.M.1
Balachandran, V.P.2
Ocuin, L.M.3
Obaid, H.4
Plitas, G.5
DeMatteo, R.P.6
-
98
-
-
61749099391
-
Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
-
doi:10.1172/JCI35958
-
Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest (2009) 119:305-14. doi:10.1172/JCI35958.
-
(2009)
J Clin Invest
, vol.119
, pp. 305-314
-
-
Imaeda, A.B.1
Watanabe, A.2
Sohail, M.A.3
Mahmood, S.4
Mohamadnejad, M.5
Sutterwala, F.S.6
-
99
-
-
84856350648
-
Role of innate immunity and the microbiota in liver fibrosis-crosstalk between the liver and gut
-
doi:10.1113/jphysiol.2011.219691
-
Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis-crosstalk between the liver and gut. J Physiol (2012) 590:447-58. doi:10.1113/jphysiol.2011.219691.
-
(2012)
J Physiol
, vol.590
, pp. 447-458
-
-
Seki, E.1
Schnabl, B.2
-
100
-
-
84855174006
-
Gut microbiota is a key modulator of insulin resistance in TLR2 knockout mice
-
doi:10.1371/journal.pbio.1001212
-
Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, et al. Gut microbiota is a key modulator of insulin resistance in TLR2 knockout mice. PLoS Biol (2011) 9:e1001212. doi:10.1371/journal.pbio.1001212.
-
(2011)
PLoS Biol
, vol.9
-
-
Caricilli, A.M.1
Picardi, P.K.2
de Abreu, L.L.3
Ueno, M.4
Prada, P.O.5
Ropelle, E.R.6
-
101
-
-
77953601881
-
Regulation of innate immune responses by autophagy-related proteins
-
doi:10.1083/jcb.201002021
-
Saitoh T, Akira S. Regulation of innate immune responses by autophagy-related proteins. J Cell Biol (2010) 189:925-35. doi:10.1083/jcb.201002021.
-
(2010)
J Cell Biol
, vol.189
, pp. 925-935
-
-
Saitoh, T.1
Akira, S.2
-
102
-
-
56249090667
-
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production
-
doi:10.1038/nature07383
-
Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 456:264-8. doi:10.1038/nature07383.
-
(2008)
Nature
, vol.456
, pp. 264-268
-
-
Saitoh, T.1
Fujita, N.2
Jang, M.H.3
Uematsu, S.4
Yang, B.G.5
Satoh, T.6
-
103
-
-
78149475088
-
Regulation of mammalian autophagy in physiology and pathophysiology
-
doi:10.1152/physrev.00030.2009
-
Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev (2010) 90:1383-435. doi:10.1152/physrev.00030.2009.
-
(2010)
Physiol Rev
, vol.90
, pp. 1383-1435
-
-
Ravikumar, B.1
Sarkar, S.2
Davies, J.E.3
Futter, M.4
Garcia-Arencibia, M.5
Green-Thompson, Z.W.6
-
104
-
-
84868028602
-
Suppression of autophagy sensitizes Kupffer cells to endotoxin
-
doi:10.1111/j.1872-034X.2012.01024.x
-
Fukada H, Yamashina S, Izumi K, Komatsu M, Tanaka K, Ikejima K, et al. Suppression of autophagy sensitizes Kupffer cells to endotoxin. Hepatol Res (2012) 42:1112-8. doi:10.1111/j.1872-034X.2012.01024.x.
-
(2012)
Hepatol Res
, vol.42
, pp. 1112-1118
-
-
Fukada, H.1
Yamashina, S.2
Izumi, K.3
Komatsu, M.4
Tanaka, K.5
Ikejima, K.6
-
105
-
-
66749174867
-
The inflammasomes: guardians of the body
-
doi:10.1146/annurev.immunol.021908.132715
-
Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 27:229-65. doi:10.1146/annurev.immunol.021908.132715.
-
(2009)
Annu Rev Immunol
, vol.27
, pp. 229-265
-
-
Martinon, F.1
Mayor, A.2
Tschopp, J.3
-
106
-
-
64049096349
-
Sensing pathogens and danger signals by the inflammasome
-
doi:10.1016/j.coi.2009.01.006
-
Pedra JH, Cassel SL, Sutterwala FS. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol (2009) 21:10-6. doi:10.1016/j.coi.2009.01.006.
-
(2009)
Curr Opin Immunol
, vol.21
, pp. 10-16
-
-
Pedra, J.H.1
Cassel, S.L.2
Sutterwala, F.S.3
-
107
-
-
76249120134
-
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
-
doi:10.1038/nm.2087
-
Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med (2010) 16:228-31. doi:10.1038/nm.2087.
-
(2010)
Nat Med
, vol.16
, pp. 228-231
-
-
Clarke, T.B.1
Davis, K.M.2
Lysenko, E.S.3
Zhou, A.Y.4
Yu, Y.5
Weiser, J.N.6
-
108
-
-
82955249021
-
NOD-like receptors and the innate immune system: coping with danger, damage and death
-
doi:10.1016/j.cytogfr.2011.09.003
-
Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P. NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev (2011) 22:257-76. doi:10.1016/j.cytogfr.2011.09.003.
-
(2011)
Cytokine Growth Factor Rev
, vol.22
, pp. 257-276
-
-
Kersse, K.1
Bertrand, M.J.2
Lamkanfi, M.3
Vandenabeele, P.4
-
109
-
-
34547743231
-
The inflammasome in pathogen recognition and inflammation
-
doi:10.1189/jlb.1206755
-
Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol (2007) 82:259-64. doi:10.1189/jlb.1206755.
-
(2007)
J Leukoc Biol
, vol.82
, pp. 259-264
-
-
Sutterwala, F.S.1
Ogura, Y.2
Flavell, R.A.3
-
110
-
-
84855989829
-
Inflammasomes in health and disease
-
doi:10.1038/nature10759
-
Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature (2012) 481:278-86. doi:10.1038/nature10759.
-
(2012)
Nature
, vol.481
, pp. 278-286
-
-
Strowig, T.1
Henao-Mejia, J.2
Elinav, E.3
Flavell, R.4
-
111
-
-
62649139025
-
Immunological and inflammatory functions of the interleukin-1 family
-
doi:10.1146/annurev.immunol.021908.132612
-
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 27:519-50. doi:10.1146/annurev.immunol.021908.132612.
-
(2009)
Annu Rev Immunol
, vol.27
, pp. 519-550
-
-
Dinarello, C.A.1
-
112
-
-
79959573042
-
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
-
doi:10.1002/hep.24341
-
Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology (2011) 54:133-44. doi:10.1002/hep.24341.
-
(2011)
Hepatology
, vol.54
, pp. 133-144
-
-
Csak, T.1
Ganz, M.2
Pespisa, J.3
Kodys, K.4
Dolganiuc, A.5
Szabo, G.6
-
113
-
-
84873573078
-
Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis
-
doi:10.1371/journal.pone.0056100
-
Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One (2013) 8:e56100. doi:10.1371/journal.pone.0056100.
-
(2013)
PLoS One
, vol.8
-
-
Dixon, L.J.1
Flask, C.A.2
Papouchado, B.G.3
Feldstein, A.E.4
Nagy, L.E.5
-
114
-
-
79955038882
-
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
-
doi:10.1038/ni.2022
-
Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 12:408-15. doi:10.1038/ni.2022.
-
(2011)
Nat Immunol
, vol.12
, pp. 408-415
-
-
Wen, H.1
Gris, D.2
Lei, Y.3
Jha, S.4
Zhang, L.5
Huang, M.T.6
-
115
-
-
80053087484
-
Inflammasome is a central player in the induction of obesity and insulin resistance
-
doi:10.1073/pnas.1100255108
-
Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 108:15324-9. doi:10.1073/pnas.1100255108.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 15324-15329
-
-
Stienstra, R.1
van Diepen, J.A.2
Tack, C.J.3
Zaki, M.H.4
van de Veerdonk, F.L.5
Perera, D.6
-
116
-
-
84867176929
-
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
-
doi:10.1172/JCI60777
-
Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest (2012) 122:3476-89. doi:10.1172/JCI60777.
-
(2012)
J Clin Invest
, vol.122
, pp. 3476-3489
-
-
Petrasek, J.1
Bala, S.2
Csak, T.3
Lippai, D.4
Kodys, K.5
Menashy, V.6
-
117
-
-
84865132718
-
Inflammasomes in liver diseases
-
doi:10.1016/j.jhep.2012.03.035
-
Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol (2012) 57:642-54. doi:10.1016/j.jhep.2012.03.035.
-
(2012)
J Hepatol
, vol.57
, pp. 642-654
-
-
Szabo, G.1
Csak, T.2
-
118
-
-
79960371987
-
Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice
-
doi:10.1089/hum.2010.145
-
Zhu P, Duan L, Chen J, Xiong A, Xu Q, Zhang H, et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther (2011) 22:853-64. doi:10.1089/hum.2010.145.
-
(2011)
Hum Gene Ther
, vol.22
, pp. 853-864
-
-
Zhu, P.1
Duan, L.2
Chen, J.3
Xiong, A.4
Xu, Q.5
Zhang, H.6
-
119
-
-
70249138036
-
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
-
doi:10.4049/jimmunol.0901363
-
Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol (2009) 183:787-91. doi:10.4049/jimmunol.0901363.
-
(2009)
J Immunol
, vol.183
, pp. 787-791
-
-
Bauernfeind, F.G.1
Horvath, G.2
Stutz, A.3
Alnemri, E.S.4
MacDonald, K.5
Speert, D.6
-
120
-
-
82455205872
-
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
-
doi:10.3748/wjg.v17.i43.4772
-
Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol (2011) 17:4772-8. doi:10.3748/wjg.v17.i43.4772.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 4772-4778
-
-
Ganz, M.1
Csak, T.2
Nath, B.3
Szabo, G.4
-
121
-
-
0027168655
-
Homology between the mammalian liver and Drosophila fat body
-
doi:10.1016/0168-9525(93)90113-V
-
Sondergaard L. Homology between the mammalian liver and Drosophila fat body. Trends Genet (1993) 9:193. doi:10.1016/0168-9525(93)90113-V.
-
(1993)
Trends Genet
, vol.9
, pp. 193
-
-
Sondergaard, L.1
-
122
-
-
0346157290
-
Innate immunity: an overview
-
doi:10.1016/j.molimm.2003.10.005
-
Beutler B. Innate immunity: an overview. Mol Immunol (2004) 40:845-59. doi:10.1016/j.molimm.2003.10.005.
-
(2004)
Mol Immunol
, vol.40
, pp. 845-859
-
-
Beutler, B.1
-
123
-
-
33750584214
-
TLR4 links innate immunity and fatty acid-induced insulin resistance
-
doi:10.1172/JCI28898
-
Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 116:3015-25. doi:10.1172/JCI28898.
-
(2006)
J Clin Invest
, vol.116
, pp. 3015-3025
-
-
Shi, H.1
Kokoeva, M.V.2
Inouye, K.3
Tzameli, I.4
Yin, H.5
Flier, J.S.6
-
124
-
-
33845866857
-
Inflammation and metabolic disorders
-
doi:10.1038/nature05485
-
Hotamisligil GS. Inflammation and metabolic disorders. Nature (2006) 444:860-7. doi:10.1038/nature05485.
-
(2006)
Nature
, vol.444
, pp. 860-867
-
-
Hotamisligil, G.S.1
-
125
-
-
70349484669
-
Mechanisms of obesity and related pathology: linking immune responses to metabolic stress
-
doi:10.1111/j.1742-4658.2009.07304.x
-
Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J (2009) 276:5747-54. doi:10.1111/j.1742-4658.2009.07304.x.
-
(2009)
FEBS J
, vol.276
, pp. 5747-5754
-
-
Karalis, K.P.1
Giannogonas, P.2
Kodela, E.3
Koutmani, Y.4
Zoumakis, M.5
Teli, T.6
-
126
-
-
33644824915
-
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes
-
doi:10.1210/jc.2005-1159
-
Gastaldelli A, Miyazaki Y, Pettiti M, Santini E, Ciociaro D, Defronzo RA, et al. The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 91:806-12. doi:10.1210/jc.2005-1159.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 806-812
-
-
Gastaldelli, A.1
Miyazaki, Y.2
Pettiti, M.3
Santini, E.4
Ciociaro, D.5
Defronzo, R.A.6
-
127
-
-
20944450486
-
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
-
doi:10.1007/s00125-005-1682-x
-
Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 48:634-42. doi:10.1007/s00125-005-1682-x.
-
(2005)
Diabetologia
, vol.48
, pp. 634-642
-
-
Bugianesi, E.1
Gastaldelli, A.2
Vanni, E.3
Gambino, R.4
Cassader, M.5
Baldi, S.6
-
128
-
-
0036312905
-
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
-
doi:10.1210/jcem.87.7.8638
-
Seppala-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab (2002) 87:3023-8. doi:10.1210/jcem.87.7.8638.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3023-3028
-
-
Seppala-Lindroos, A.1
Vehkavaara, S.2
Häkkinen, A.M.3
Goto, T.4
Westerbacka, J.5
Sovijärvi, A.6
-
129
-
-
34547514221
-
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
-
doi:10.1053/j.gastro.2007.04.068
-
Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology (2007) 133:496-506. doi:10.1053/j.gastro.2007.04.068.
-
(2007)
Gastroenterology
, vol.133
, pp. 496-506
-
-
Gastaldelli, A.1
Cusi, K.2
Pettiti, M.3
Hardies, J.4
Miyazaki, Y.5
Berria, R.6
-
130
-
-
73949147212
-
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status
-
doi:10.1007/s12325-009-0072-z
-
Stein LL, Dong MH, Loomba R. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. Adv Ther (2009) 26:893-907. doi:10.1007/s12325-009-0072-z.
-
(2009)
Adv Ther
, vol.26
, pp. 893-907
-
-
Stein, L.L.1
Dong, M.H.2
Loomba, R.3
-
131
-
-
47149111845
-
Metformin use in children with nonalcoholic fatty liver disease: an open label, 24-month, observational pilot study
-
doi:10.1016/j.clinthera.2008.06.012
-
Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, et al. Metformin use in children with nonalcoholic fatty liver disease: an open label, 24-month, observational pilot study. Clin Ther (2008) 30:1168-76. doi:10.1016/j.clinthera.2008.06.012.
-
(2008)
Clin Ther
, vol.30
, pp. 1168-1176
-
-
Nobili, V.1
Manco, M.2
Ciampalini, P.3
Alisi, A.4
Devito, R.5
Bugianesi, E.6
-
132
-
-
2942655390
-
Evidence for a potent antiinflammatory effect of rosiglitazone
-
doi:10.1210/jc.2003-032103
-
Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, et al. Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab (2004) 89:2728-35. doi:10.1210/jc.2003-032103.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2728-2735
-
-
Mohanty, P.1
Aljada, A.2
Ghanim, H.3
Hofmeyer, D.4
Tripathy, D.5
Syed, T.6
-
133
-
-
34548306770
-
The effects of discontinuing pioglitazone in patients with non-alcoholic steatohepatitis
-
doi:10.1002/hep.21661
-
Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, et al. The effects of discontinuing pioglitazone in patients with non-alcoholic steatohepatitis. Hepatology (2007) 46:424-9. doi:10.1002/hep.21661.
-
(2007)
Hepatology
, vol.46
, pp. 424-429
-
-
Lutchman, G.1
Modi, A.2
Kleiner, D.E.3
Promrat, K.4
Heller, T.5
Ghany, M.6
-
134
-
-
84864290671
-
Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies
-
doi:10.1007/s10620-012-2118-3
-
Nseir W, Mograbi J, Ghali M. Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. Dig Dis Sci (2012) 57:1773-81. doi:10.1007/s10620-012-2118-3.
-
(2012)
Dig Dis Sci
, vol.57
, pp. 1773-1781
-
-
Nseir, W.1
Mograbi, J.2
Ghali, M.3
-
135
-
-
56649094325
-
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
-
doi:10.1055/s-0028-1091980
-
Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis (2008) 28:360-9. doi:10.1055/s-0028-1091980.
-
(2008)
Semin Liver Dis
, vol.28
, pp. 360-369
-
-
Malhi, H.1
Gores, G.J.2
-
136
-
-
70049089646
-
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
-
doi:10.1586/egh.09.32
-
Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol (2009) 3:445-51. doi:10.1586/egh.09.32.
-
(2009)
Expert Rev Gastroenterol Hepatol
, vol.3
, pp. 445-451
-
-
Alkhouri, N.1
Dixon, L.J.2
Feldstein, A.E.3
-
137
-
-
34247863931
-
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease
-
doi:10.1053/j.gastro.2007.03.055
-
Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology (2007) 132:2191-207. doi:10.1053/j.gastro.2007.03.055.
-
(2007)
Gastroenterology
, vol.132
, pp. 2191-2207
-
-
Parekh, S.1
Anania, F.A.2
-
138
-
-
77951875017
-
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
-
doi:10.1016/S0140-6736(10)60545-4
-
Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet (2010) 375:1634-9. doi:10.1016/S0140-6736(10)60545-4.
-
(2010)
Lancet
, vol.375
, pp. 1634-1639
-
-
Sarwar, N.1
Sandhu, M.S.2
Ricketts, S.L.3
Butterworth, A.S.4
Di Angelantonio, E.5
Boekholdt, S.M.6
-
139
-
-
78049522194
-
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis
-
doi:10.1002/hep.24001
-
Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology (2010) 52:1836-46. doi:10.1002/hep.24001.
-
(2010)
Hepatology
, vol.52
, pp. 1836-1846
-
-
Tilg, H.1
Moschen, A.R.2
-
140
-
-
3042824524
-
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway
-
doi:10.1002/hep.20283
-
Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 40:185-94. doi:10.1002/hep.20283.
-
(2004)
Hepatology
, vol.40
, pp. 185-194
-
-
Feldstein, A.E.1
Werneburg, N.W.2
Canbay, A.3
Guicciardi, M.E.4
Bronk, S.F.5
Rydzewski, R.6
-
141
-
-
77649337140
-
Nonalcoholic fatty liver disease: pathology and pathogenesis
-
doi:10.1146/annurev-pathol-121808-102132
-
Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol (2010) 5:145-71. doi:10.1146/annurev-pathol-121808-102132.
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 145-171
-
-
Tiniakos, D.G.1
Vos, M.B.2
Brunt, E.M.3
-
142
-
-
39149104311
-
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
-
doi:10.1016/j.molmed.2007.12.003
-
Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med (2008) 14:72-81. doi:10.1016/j.molmed.2007.12.003.
-
(2008)
Trends Mol Med
, vol.14
, pp. 72-81
-
-
Marra, F.1
Gastaldelli, A.2
Svegliati Baroni, G.3
Tell, G.4
Tiribelli, C.5
-
143
-
-
84883746590
-
The innate immune response during liver inflammation and metabolic disease
-
doi:10.1016/j.it.2013.04.005
-
Bieghs V, Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol (2013) 34:446-52. doi:10.1016/j.it.2013.04.005.
-
(2013)
Trends Immunol
, vol.34
, pp. 446-452
-
-
Bieghs, V.1
Trautwein, C.2
-
144
-
-
0034676629
-
Cytokines in alcoholic and nonalcoholic steatohepatitis
-
doi:10.1056/NEJM200011163432007
-
Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 343:1467-76. doi:10.1056/NEJM200011163432007.
-
(2000)
N Engl J Med
, vol.343
, pp. 1467-1476
-
-
Tilg, H.1
Diehl, A.M.2
-
145
-
-
38349107613
-
Adipokines and cytokines in non-alcoholic fatty liver disease
-
doi:10.1111/j.1365-2036.2007.03586.x
-
Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2008) 27:412-21. doi:10.1111/j.1365-2036.2007.03586.x.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 412-421
-
-
Jarrar, M.H.1
Baranova, A.2
Collantes, R.3
Ranard, B.4
Stepanova, M.5
Bennett, C.6
-
146
-
-
0035183475
-
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
-
doi:10.1053/jhep.2001.29628
-
Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology (2001) 34:1158-63. doi:10.1053/jhep.2001.29628.
-
(2001)
Hepatology
, vol.34
, pp. 1158-1163
-
-
Crespo, J.1
Cayon, A.2
Fernandez-Gil, P.3
Hernandez-Guerra, M.4
Mayorga, M.5
Dominguez-Diez, A.6
-
147
-
-
34247554214
-
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
-
doi:10.1016/j.jhep.2007.01.028
-
Tokushige K, Takakura M, Tsuchiya-Matsushita N, Taniai M, Hashimoto E, Shiratori K. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol (2007) 46:1104-10. doi:10.1016/j.jhep.2007.01.028.
-
(2007)
J Hepatol
, vol.46
, pp. 1104-1110
-
-
Tokushige, K.1
Takakura, M.2
Tsuchiya-Matsushita, N.3
Taniai, M.4
Hashimoto, E.5
Shiratori, K.6
-
148
-
-
34748903504
-
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
-
doi:10.1677/JOE-07-0234
-
Barbuio R, Milanski M, Bertolo MB, Saad MJ, Velloso LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol (2007) 194:539-50. doi:10.1677/JOE-07-0234.
-
(2007)
J Endocrinol
, vol.194
, pp. 539-550
-
-
Barbuio, R.1
Milanski, M.2
Bertolo, M.B.3
Saad, M.J.4
Velloso, L.A.5
-
149
-
-
0037309589
-
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
-
doi:10.1053/jhep.2003.50048
-
Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology (2003) 37:343-50. doi:10.1053/jhep.2003.50048.
-
(2003)
Hepatology
, vol.37
, pp. 343-350
-
-
Li, Z.1
Yang, S.2
Lin, H.3
Huang, J.4
Watkins, P.A.5
Moser, A.B.6
-
150
-
-
80054848953
-
Systemic blockade of TNF-a does not improve insulin resistance in humans
-
doi:10.1055/s-0031-1287783
-
Ferraz-Amaro I, Arce-Franco M, Muniz J, López-Fernández J, Hernández-Hernández V, Franco A, et al. Systemic blockade of TNF-a does not improve insulin resistance in humans. Horm Metab Res (2011) 43:801-8. doi:10.1055/s-0031-1287783.
-
(2011)
Horm Metab Res
, vol.43
, pp. 801-808
-
-
Ferraz-Amaro, I.1
Arce-Franco, M.2
Muniz, J.3
López-Fernández, J.4
Hernández-Hernández, V.5
Franco, A.6
-
151
-
-
79952856377
-
Chronic TNF-a neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome
-
doi:10.2119/molmed.2010.00221
-
Wascher TC, Lindeman JH, Sourij H, Kooistra T, Pacini G, Roden M. Chronic TNF-a neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome. Mol Med (2011) 17:189-93. doi:10.2119/molmed.2010.00221.
-
(2011)
Mol Med
, vol.17
, pp. 189-193
-
-
Wascher, T.C.1
Lindeman, J.H.2
Sourij, H.3
Kooistra, T.4
Pacini, G.5
Roden, M.6
-
152
-
-
11144249271
-
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
-
doi:10.1111/j.1572-0241.2004.40064.x
-
Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 99:2365-8. doi:10.1111/j.1572-0241.2004.40064.x.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 2365-2368
-
-
Adams, L.A.1
Zein, C.O.2
Angulo, P.3
Lindor, K.D.4
-
153
-
-
7044269614
-
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
-
doi:10.1111/j.1572-0241.2004.40220.x
-
Satapathy SK, Garg S, Chauhan R, Sakhuja P, Malhotra V, Sharma BC, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2004) 99:1946-52. doi:10.1111/j.1572-0241.2004.40220.x.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1946-1952
-
-
Satapathy, S.K.1
Garg, S.2
Chauhan, R.3
Sakhuja, P.4
Malhotra, V.5
Sharma, B.C.6
-
154
-
-
23044468612
-
Interleukin-6 depletion selectively improves hepatic insulin action in obesity
-
doi:10.1210/en.2004-1468
-
Klover PJ, Clementi AH, Mooney RA. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology (2005) 146:3417-27. doi:10.1210/en.2004-1468.
-
(2005)
Endocrinology
, vol.146
, pp. 3417-3427
-
-
Klover, P.J.1
Clementi, A.H.2
Mooney, R.A.3
-
155
-
-
57349101675
-
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance
-
doi:10.1126/science.1160794
-
Sabio G, Das M, Mora A, Zhang Z, Jun JY, Barrett T, et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 322:1539-43. doi:10.1126/science.1160794.
-
(2008)
Science
, vol.322
, pp. 1539-1543
-
-
Sabio, G.1
Das, M.2
Mora, A.3
Zhang, Z.4
Jun, J.Y.5
Barrett, T.6
-
156
-
-
84884410878
-
Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice
-
doi:10.1152/ajpgi.00450.2012
-
Mastrocola R, Collino M, Rogazzo M, Medana C, Nigro D, Boccuzzi G, et al. Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice. Am J Physiol Gastrointest Liver Physiol (2013) 305:G398-407. doi:10.1152/ajpgi.00450.2012.
-
(2013)
Am J Physiol Gastrointest Liver Physiol
, vol.305
-
-
Mastrocola, R.1
Collino, M.2
Rogazzo, M.3
Medana, C.4
Nigro, D.5
Boccuzzi, G.6
-
157
-
-
84896398724
-
Dietary glycotoxins exacerbate progression of experimental fatty liver disease
-
doi:10.1016/j.jhep.2013.11.033
-
Leung C, Herath CB, Jia Z, Goodwin M, Mak KY, Watt MJ, et al. Dietary glycotoxins exacerbate progression of experimental fatty liver disease. J Hepatol (2014) 60:832-8. doi:10.1016/j.jhep.2013.11.033.
-
(2014)
J Hepatol
, vol.60
, pp. 832-838
-
-
Leung, C.1
Herath, C.B.2
Jia, Z.3
Goodwin, M.4
Mak, K.Y.5
Watt, M.J.6
-
158
-
-
77956544806
-
At the crossroad between immunity and metabolism: focus on leptin
-
doi:10.1586/eci.10.48
-
Conde J, Scotece M, Gómez R, Gómez-Reino JJ, Lago F, Gualillo O. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol (2010) 6:801-8. doi:10.1586/eci.10.48.
-
(2010)
Expert Rev Clin Immunol
, vol.6
, pp. 801-808
-
-
Conde, J.1
Scotece, M.2
Gómez, R.3
Gómez-Reino, J.J.4
Lago, F.5
Gualillo, O.6
-
159
-
-
3042543880
-
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats
-
doi:10.1210/en.2004-0129
-
Meli R, Pacilio M, Mattace Raso G, Esposito E, Coppola A, Nasti A, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology (2004) 145:3115-21. doi:10.1210/en.2004-0129.
-
(2004)
Endocrinology
, vol.145
, pp. 3115-3121
-
-
Meli, R.1
Pacilio, M.2
Mattace Raso, G.3
Esposito, E.4
Coppola, A.5
Nasti, A.6
-
160
-
-
34748925051
-
Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation
-
doi:10.1677/JOE-07-0159
-
Mattace Raso G, Bianco G, Iacono A, Esposito E, Autore G, Ferrante MC, et al. Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation. J Endocrinol (2007) 194:611-9. doi:10.1677/JOE-07-0159.
-
(2007)
J Endocrinol
, vol.194
, pp. 611-619
-
-
Mattace Raso, G.1
Bianco, G.2
Iacono, A.3
Esposito, E.4
Autore, G.5
Ferrante, M.C.6
-
161
-
-
84897873973
-
Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats
-
doi:10.1210/en.2013-1823
-
Mattace Raso G, Santoro A, Russo R, Simeoli R, Paciello O, Di Carlo C, et al. Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats. Endocrinology (2014) 155:1291-301. doi:10.1210/en.2013-1823.
-
(2014)
Endocrinology
, vol.155
, pp. 1291-1301
-
-
Mattace Raso, G.1
Santoro, A.2
Russo, R.3
Simeoli, R.4
Paciello, O.5
Di Carlo, C.6
-
162
-
-
65549128076
-
Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression
-
doi:10.2337/db08-0775
-
Yuen DY, Dwyer RM, Matthews VB, Zhang L, Drew BG, Neill B, et al. Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression. Diabetes (2009) 58:1086-95. doi:10.2337/db08-0775.
-
(2009)
Diabetes
, vol.58
, pp. 1086-1095
-
-
Yuen, D.Y.1
Dwyer, R.M.2
Matthews, V.B.3
Zhang, L.4
Drew, B.G.5
Neill, B.6
-
163
-
-
84879459608
-
Inflammation, cytokines and insulin resistance: a clinical perspective
-
doi:10.1007/s00005-012-0210-1
-
Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) (2013) 61:119-25. doi:10.1007/s00005-012-0210-1.
-
(2013)
Arch Immunol Ther Exp (Warsz)
, vol.61
, pp. 119-125
-
-
Wieser, V.1
Moschen, A.R.2
Tilg, H.3
-
164
-
-
79955807238
-
Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
-
doi:10.1136/ard.2010.132845
-
Ogata A, Morishima A, Hirano T, Hishitani Y, Hagihara K, Shima Y, et al. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. Ann Rheum Dis (2011) 70:1164-5. doi:10.1136/ard.2010.132845.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1164-1165
-
-
Ogata, A.1
Morishima, A.2
Hirano, T.3
Hishitani, Y.4
Hagihara, K.5
Shima, Y.6
-
165
-
-
78650781728
-
Effects of inhibition of interleukin-6 signaling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases
-
doi:10.1371/journal.pone.0014328
-
Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, et al. Effects of inhibition of interleukin-6 signaling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One (2010) 5:e14328. doi:10.1371/journal.pone.0014328.
-
(2010)
PLoS One
, vol.5
-
-
Schultz, O.1
Oberhauser, F.2
Saech, J.3
Rubbert-Roth, A.4
Hahn, M.5
Krone, W.6
-
166
-
-
0031439778
-
Leptin selectively decreases visceral adiposity and enhances insulin action
-
doi:10.1172/JCI119865
-
Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest (1997) 100:3105-10. doi:10.1172/JCI119865.
-
(1997)
J Clin Invest
, vol.100
, pp. 3105-3110
-
-
Barzilai, N.1
Wang, J.2
Massilon, D.3
Vuguin, P.4
Hawkins, M.5
Rossetti, L.6
-
167
-
-
0035658444
-
Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis
-
Reddy JK. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2001) 281:G1333-9.
-
(2001)
Am J Physiol Gastrointest Liver Physiol
, vol.281
-
-
Reddy, J.K.1
-
169
-
-
18144444592
-
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis
-
doi:10.1053/jhep.2003.50398
-
Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology (2003) 38:999-1007. doi:10.1053/jhep.2003.50398.
-
(2003)
Hepatology
, vol.38
, pp. 999-1007
-
-
Pérez-Carreras, M.1
Del Hoyo, P.2
Martín, M.A.3
Rubio, J.C.4
Martín, A.5
Castellano, G.6
-
170
-
-
0042165989
-
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
-
doi:10.1016/S0016-5085(03)00907-7
-
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 125:437-43. doi:10.1016/S0016-5085(03)00907-7.
-
(2003)
Gastroenterology
, vol.125
, pp. 437-443
-
-
Feldstein, A.E.1
Canbay, A.2
Angulo, P.3
Taniai, M.4
Burgart, L.J.5
Lindor, K.D.6
-
171
-
-
0024362244
-
Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease
-
doi:10.3109/00365528909093067
-
Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, et al. Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol (1989) 24:407-15. doi:10.3109/00365528909093067.
-
(1989)
Scand J Gastroenterol
, vol.24
, pp. 407-415
-
-
Vendemiale, G.1
Altomare, E.2
Trizio, T.3
Le Grazie, C.4
Di Padova, C.5
Salerno, M.T.6
-
172
-
-
58949093381
-
Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat
-
doi:10.1016/j.ejphar.2008.12.013
-
Mattace Raso G, Esposito E, Iacono A, Pacilio M, Cuzzocrea S, Berni Canani R, et al. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. Eur J Pharmacol (2009) 604:125-31. doi:10.1016/j.ejphar.2008.12.013.
-
(2009)
Eur J Pharmacol
, vol.604
, pp. 125-131
-
-
Mattace Raso, G.1
Esposito, E.2
Iacono, A.3
Pacilio, M.4
Cuzzocrea, S.5
Berni Canani, R.6
-
173
-
-
84856093034
-
Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice
-
doi:10.1016/j.lfs.2011.11.012
-
Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, et al. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Life Sci (2012) 90:200-5. doi:10.1016/j.lfs.2011.11.012.
-
(2012)
Life Sci
, vol.90
, pp. 200-205
-
-
Min, A.K.1
Kim, M.K.2
Kim, H.S.3
Seo, H.Y.4
Lee, K.U.5
Kim, J.G.6
-
174
-
-
3142634597
-
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study
-
doi:10.1097/00005176-200401000-00012
-
Vajro P, Mandato C, Franzese A, Ciccimarra E, Lucariello S, Savoia M, et al. Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J Pediatr Gastroenterol Nutr (2004) 38:48-55. doi:10.1097/00005176-200401000-00012.
-
(2004)
J Pediatr Gastroenterol Nutr
, vol.38
, pp. 48-55
-
-
Vajro, P.1
Mandato, C.2
Franzese, A.3
Ciccimarra, E.4
Lucariello, S.5
Savoia, M.6
-
175
-
-
84868217713
-
Vitamin E and nonalcoholic fatty liver disease
-
doi:10.1097/MCO.0b013e328357f747
-
Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care (2012) 15:641-8. doi:10.1097/MCO.0b013e328357f747.
-
(2012)
Curr Opin Clin Nutr Metab Care
, vol.15
, pp. 641-648
-
-
Pacana, T.1
Sanyal, A.J.2
-
176
-
-
84879242918
-
Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN). Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
-
doi:10.1111/apt.12352
-
Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, et al. Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN). Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2013) 38:134-43. doi:10.1111/apt.12352.
-
(2013)
Aliment Pharmacol Ther
, vol.38
, pp. 134-143
-
-
Hoofnagle, J.H.1
Van Natta, M.L.2
Kleiner, D.E.3
Clark, J.M.4
Kowdley, K.V.5
Loomba, R.6
-
177
-
-
84879830881
-
Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet
-
doi:10.1371/journal.pone.0068626
-
Mattace Raso G, Simeoli R, Russo R, Iacono A, Santoro A, Paciello O, et al. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS One (2013) 8:e68626. doi:10.1371/journal.pone.0068626.
-
(2013)
PLoS One
, vol.8
-
-
Mattace Raso, G.1
Simeoli, R.2
Russo, R.3
Iacono, A.4
Santoro, A.5
Paciello, O.6
-
178
-
-
79960299110
-
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms
-
doi:10.1016/j.jnutbio.2010.10.002
-
Iacono A, Mattace Raso G, Berni Canani R, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem (2011) 22:699-711. doi:10.1016/j.jnutbio.2010.10.002.
-
(2011)
J Nutr Biochem
, vol.22
, pp. 699-711
-
-
Iacono, A.1
Mattace Raso, G.2
Berni Canani, R.3
Calignano, A.4
Meli, R.5
-
179
-
-
79955932718
-
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
-
doi:10.3748/wjg.v17.i12.1519
-
Berni Canani R, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol (2011) 17:1519-28. doi:10.3748/wjg.v17.i12.1519.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 1519-1528
-
-
Berni Canani, R.1
Di Costanzo, M.2
Leone, L.3
Pedata, M.4
Meli, R.5
Calignano, A.6
-
180
-
-
0031019249
-
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia
-
doi:10.1038/ng0397-269
-
Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet (1997) 15:269-72. doi:10.1038/ng0397-269.
-
(1997)
Nat Genet
, vol.15
, pp. 269-272
-
-
Fleury, C.1
Neverova, M.2
Collins, S.3
Raimbault, S.4
Champigny, O.5
Levi-Meyrueis, C.6
-
181
-
-
7844237506
-
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression
-
doi:10.1210/endo.139.12.6384
-
Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, et al. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology (1998) 139:4920-7. doi:10.1210/endo.139.12.6384.
-
(1998)
Endocrinology
, vol.139
, pp. 4920-4927
-
-
Kelly, L.J.1
Vicario, P.P.2
Thompson, G.M.3
Candelore, M.R.4
Doebber, T.W.5
Ventre, J.6
-
182
-
-
0033605261
-
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
-
doi:10.1074/jbc.274.9.5692
-
Chavin KD, Yang SQ, Lin HZ, Chatham J, Chacko VP, Hoek JB, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 274:5692-700. doi:10.1074/jbc.274.9.5692.
-
(1999)
J Biol Chem
, vol.274
, pp. 5692-5700
-
-
Chavin, K.D.1
Yang, S.Q.2
Lin, H.Z.3
Chatham, J.4
Chacko, V.P.5
Hoek, J.B.6
-
183
-
-
0032898080
-
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver
-
doi:10.1002/hep.510290428
-
Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 29:1131-8. doi:10.1002/hep.510290428.
-
(1999)
Hepatology
, vol.29
, pp. 1131-1138
-
-
Rashid, A.1
Wu, T.C.2
Huang, C.C.3
Chen, C.H.4
Lin, H.Z.5
Yang, S.Q.6
-
184
-
-
0031829766
-
The uncoupling proteins, a review
-
doi:10.1530/eje.0.1390001
-
Boss O, Muzzin P, Giacobino JP. The uncoupling proteins, a review. Eur J Endocrinol (1998) 139:1-9. doi:10.1530/eje.0.1390001.
-
(1998)
Eur J Endocrinol
, vol.139
, pp. 1-9
-
-
Boss, O.1
Muzzin, P.2
Giacobino, J.P.3
-
185
-
-
0033392903
-
Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control "the benefits of losing control"
-
doi:10.1023/A:1005452624640
-
Diehl AM, Hoek JB. Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control "the benefits of losing control". J Bioenerg Biomembr (1999) 31:493-506. doi:10.1023/A:1005452624640.
-
(1999)
J Bioenerg Biomembr
, vol.31
, pp. 493-506
-
-
Diehl, A.M.1
Hoek, J.B.2
-
186
-
-
0001513966
-
Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis
-
doi:10.1073/pnas.94.6.2557
-
Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A (1997) 94:2557-62. doi:10.1073/pnas.94.6.2557.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 2557-2562
-
-
Yang, S.Q.1
Lin, H.Z.2
Lane, M.D.3
Clemens, M.4
Diehl, A.M.5
-
187
-
-
0032917633
-
Leptin deficiency enhances sensitivity to endotoxin-induced lethality
-
Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol (1999) 276:R136-42.
-
(1999)
Am J Physiol
, vol.276
-
-
Faggioni, R.1
Fantuzzi, G.2
Gabay, C.3
Moser, A.4
Dinarello, C.A.5
Feingold, K.R.6
-
188
-
-
0033521601
-
Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor
-
doi:10.1084/jem.189.1.207-a
-
Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med (1999) 189:207-12. doi:10.1084/jem.189.1.207-a.
-
(1999)
J Exp Med
, vol.189
, pp. 207-212
-
-
Takahashi, N.1
Waelput, W.2
Guisez, Y.3
-
189
-
-
12344321536
-
Bacterial translocation and its consequences in patients with cirrhosis
-
doi:10.1097/00042737-200501000-00006
-
Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol (2005) 17:27-31. doi:10.1097/00042737-200501000-00006.
-
(2005)
Eur J Gastroenterol Hepatol
, vol.17
, pp. 27-31
-
-
Guarner, C.1
Soriano, G.2
-
190
-
-
14244252178
-
Bacterial translocation (BT) in cirrhosis
-
doi:10.1002/hep.20632
-
Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology (2005) 41:422-33. doi:10.1002/hep.20632.
-
(2005)
Hepatology
, vol.41
, pp. 422-433
-
-
Wiest, R.1
Garcia-Tsao, G.2
-
191
-
-
80052278497
-
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
-
doi:10.1002/emmm.201100159
-
Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 3:559-72. doi:10.1002/emmm.201100159.
-
(2011)
EMBO Mol Med
, vol.3
, pp. 559-572
-
-
Amar, J.1
Chabo, C.2
Waget, A.3
Klopp, P.4
Vachoux, C.5
Bermúdez-Humarán, L.G.6
-
192
-
-
77955492173
-
Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet
-
doi:10.1007/s00125-010-1747-3
-
Ehses JA, Meier DT, Wueest S, Rytka J, Boller S, Wielinga PY, et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia (2010) 53:1795-806. doi:10.1007/s00125-010-1747-3.
-
(2010)
Diabetologia
, vol.53
, pp. 1795-1806
-
-
Ehses, J.A.1
Meier, D.T.2
Wueest, S.3
Rytka, J.4
Boller, S.5
Wielinga, P.Y.6
-
193
-
-
34848912627
-
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia
-
doi:10.1007/s00125-007-0791-0
-
Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia (2007) 50:2374-83. doi:10.1007/s00125-007-0791-0.
-
(2007)
Diabetologia
, vol.50
, pp. 2374-2383
-
-
Cani, P.D.1
Neyrinck, A.M.2
Fava, F.3
Knauf, C.4
Burcelin, R.G.5
Tuohy, K.M.6
-
194
-
-
79955896909
-
Gut microbiota and the pathogenesis of insulin resistance
-
doi:10.1007/s11892-011-0191-1
-
Delzenne NM, Cani PD. Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep (2011) 11:154-9. doi:10.1007/s11892-011-0191-1.
-
(2011)
Curr Diab Rep
, vol.11
, pp. 154-159
-
-
Delzenne, N.M.1
Cani, P.D.2
-
195
-
-
79959199187
-
Intestinal microbiota in inflammation and insulin resistance: relevance to humans
-
doi:10.1097/MCO.0b013e328347924a
-
De Bandt JP, Waligora-Dupriet AJ, Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care (2011) 14:334-40. doi:10.1097/MCO.0b013e328347924a.
-
(2011)
Curr Opin Clin Nutr Metab Care
, vol.14
, pp. 334-340
-
-
De Bandt, J.P.1
Waligora-Dupriet, A.J.2
Butel, M.J.3
-
196
-
-
77951966791
-
Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages
-
doi:10.3305/nh.2010.25.3.4517
-
Romeo J, Nova E, Wärnberg J, Gómez-Martínez S, Díaz Ligia LE, Marcos A. Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr Hosp (2010) 25:341-9. doi:10.3305/nh.2010.25.3.4517.
-
(2010)
Nutr Hosp
, vol.25
, pp. 341-349
-
-
Romeo, J.1
Nova, E.2
Wärnberg, J.3
Gómez-Martínez, S.4
Díaz Ligia, L.E.5
Marcos, A.6
-
197
-
-
84889571833
-
Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet
-
doi:10.1016/j.jnutbio.2013.09.006
-
Mattace Raso G, Simeoli R, Iacono A, Santoro A, Amero P, Paciello O, et al. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem (2014) 25:81-90. doi:10.1016/j.jnutbio.2013.09.006.
-
(2014)
J Nutr Biochem
, vol.25
, pp. 81-90
-
-
Mattace Raso, G.1
Simeoli, R.2
Iacono, A.3
Santoro, A.4
Amero, P.5
Paciello, O.6
|